Josh Fritzler
Josh Fritzler is the Chief Financial Officer of Olympia Pharmaceuticals, a company that provides compounded GLP-1 medications, including semaglutide, to tens of thousands of patients weekly. He has expressed concerns about the stability of the national supply of GLP-1 drugs, particularly regarding continuity of care for patients as the FDA has recently declared an end to shortages of FDA-approved versions of these medications.
Global Media Ratings
Countries Mentioned
No country-level mention data available.
Interactive World Map
Each country's color is based on "Mentions" from the table above.
Recent Mentions
United States:
Josh Fritzler, chief financial officer with Olympia, voiced concerns about patient continuity of care regarding GLP-1 medications.
5